首页 > 最新文献

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases最新文献

英文 中文
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2025.100512
Salvatore Rotundo , Salvatore Nisticò , Helen Linda Morrone , Luigia Gallo , Saveria Dodaro , Carmelo Papola , Pasquale Minchella , Giovanni Matera , Francesca Greco , Luigi Principe , Lorenzo Antonio Surace , Francesco Lucia , Francesca Serapide , Alessandro Russo , Carlo Torti , Enrico Maria Trecarichi , the Calabria TB group
Tuberculosis (TB) remains a significant global health challenge, with the World Health Organization (WHO) aiming for a 95% reduction in TB deaths by 2030. Disparities in TB detection persist, particularly regarding gender, immigration status, and resistance patterns. In Calabria, Italy—a key entry point for migrants from high-TB-incidence regions—TB poses a notable public health risk. This multicenter, retrospective study examines newly diagnosed TB cases in Calabria from 2012 to 2023, focusing on rifampicin-resistant TB (RR-TB).
During this period, 800 TB cases were diagnosed, with 270 (33.7 %) in native-born Italians and 530 (66.2 %) in foreign-born individuals, showing significant differences in age (p < 0.001) and gender (p = 0.013). Among 685 patients of this cohort with available HIV status, 24 (3.5 %) were people living with HIV (PLWH), primarily from Africa, and diagnosed at higher rates of RR-TB (p < 0.001). TB cases varied by province, correlating with specific birthplaces. A total of 27 (3.4 %) RR-TB cases were identified, with heightened resistance to multiple drugs. Among these strains, 20 (74.1 %) were isoniazid-resistant (MDR-TB).
This study underscores the need for comprehensive TB control strategies, especially regarding co-infection with HIV and the emergence of drug-resistant strains, emphasizing the importance of early detection and tailored management in Southern Italy.
{"title":"Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study","authors":"Salvatore Rotundo ,&nbsp;Salvatore Nisticò ,&nbsp;Helen Linda Morrone ,&nbsp;Luigia Gallo ,&nbsp;Saveria Dodaro ,&nbsp;Carmelo Papola ,&nbsp;Pasquale Minchella ,&nbsp;Giovanni Matera ,&nbsp;Francesca Greco ,&nbsp;Luigi Principe ,&nbsp;Lorenzo Antonio Surace ,&nbsp;Francesco Lucia ,&nbsp;Francesca Serapide ,&nbsp;Alessandro Russo ,&nbsp;Carlo Torti ,&nbsp;Enrico Maria Trecarichi ,&nbsp;the Calabria TB group","doi":"10.1016/j.jctube.2025.100512","DOIUrl":"10.1016/j.jctube.2025.100512","url":null,"abstract":"<div><div>Tuberculosis (TB) remains a significant global health challenge, with the World Health Organization (WHO) aiming for a 95% reduction in TB deaths by 2030. Disparities in TB detection persist, particularly regarding gender, immigration status, and resistance patterns. In Calabria, Italy—a key entry point for migrants from high-TB-incidence regions—TB poses a notable public health risk. This multicenter, retrospective study examines newly diagnosed TB cases in Calabria from 2012 to 2023, focusing on rifampicin-resistant TB (RR-TB).</div><div>During this period, 800 TB cases were diagnosed, with 270 (33.7 %) in native-born Italians and 530 (66.2 %) in foreign-born individuals, showing significant differences in age (p &lt; 0.001) and gender (p = 0.013). Among 685 patients of this cohort with available HIV status, 24 (3.5 %) were people living with HIV (PLWH), primarily from Africa, and diagnosed at higher rates of RR-TB (p &lt; 0.001). TB cases varied by province, correlating with specific birthplaces. A total of 27 (3.4 %) RR-TB cases were identified, with heightened resistance to multiple drugs. Among these strains, 20 (74.1 %) were isoniazid-resistant (MDR-TB).</div><div>This study underscores the need for comprehensive TB control strategies, especially regarding co-infection with HIV and the emergence of drug-resistant strains, emphasizing the importance of early detection and tailored management in Southern Italy.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100512"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143153640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perforating ENL: A variant of type 2 lepra reaction 穿孔ENL: 2型lepra反应的一种变体。
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2024.100507
Bhakti Sarda , Bhushan Madke , Vikrant Saoji , Ambika Kondalkar
Lepra reactions are acute episodic inflammatory reactions that occur during illness due to abrupt changes in the body’s immunological response against Mycobacterium leprae. These are of two types, type 1 and type 2. Type 2 reaction is also called Erythema Nodosum Leprosum (ENL).
The common skin lesion in ENL is a red, tender, raised lesion. Subcutaneous nodules can also appear. The skin lesions may present as vesicles, pustules, or bulla. They can also develop ulcers and become necrotic. Some patients may experience skin lesions that resemble those seen in erythema multiforme. A rare desquamative rash may occur, which needs to be differentiated from a drug-related rash. Healing lesions may leave scars that may become inflamed during ENL flare-ups. In rare instances, there may be no skin lesions suggesting ENL.
Reactive perforating type of erythema nodosum leprosum (ENL) is a rare type 2 lepra reaction occurrence, observed in lepromatous leprosy and borderline lepromatous cases. It is linked with the involvement of several organs, so if diagnosis and treatment are delayed, it can result in complications and a grim prognosis.
麻风反应是指在患病期间,由于机体对麻风分枝杆菌的免疫反应突然发生变化而出现的急性发作性炎症反应。这些反应分为两种类型,即 1 型和 2 型。2 型反应也称为结节性红斑(ENL)。ENL常见的皮损为红色、触痛、隆起的皮损。皮下也会出现结节。皮损可表现为水泡、脓疱或鼓包。皮损还可能出现溃疡和坏死。有些患者的皮损可能与多形性红斑相似。可能会出现罕见的脱屑性皮疹,这需要与药物相关皮疹相鉴别。皮损愈合后可能会留下疤痕,在 ENL 复发时可能会发炎。在极少数情况下,可能没有皮损提示 ENL。反应性穿孔型结节性麻风红斑(ENL)是一种罕见的2型麻风反应,可见于麻风病和边缘麻风病例。它与多个器官受累有关,因此如果延误诊断和治疗,可能会导致并发症和严重的预后。
{"title":"Perforating ENL: A variant of type 2 lepra reaction","authors":"Bhakti Sarda ,&nbsp;Bhushan Madke ,&nbsp;Vikrant Saoji ,&nbsp;Ambika Kondalkar","doi":"10.1016/j.jctube.2024.100507","DOIUrl":"10.1016/j.jctube.2024.100507","url":null,"abstract":"<div><div>Lepra reactions are acute episodic inflammatory reactions that occur during illness due to abrupt changes in the body’s immunological response against Mycobacterium leprae. These are of two types, type 1 and type 2. Type 2 reaction is also called Erythema Nodosum Leprosum (ENL).</div><div>The common skin lesion in ENL is a red, tender, raised lesion. Subcutaneous nodules can also appear. The skin lesions may present as vesicles, pustules, or bulla. They can also develop ulcers and become necrotic. Some patients may experience skin lesions that resemble those seen in erythema multiforme. A rare desquamative rash may occur, which needs to be differentiated from a drug-related rash. Healing lesions may leave scars that may become inflamed during ENL flare-ups. In rare instances, there may be no skin lesions suggesting ENL.</div><div>Reactive perforating type of erythema nodosum leprosum (ENL) is a rare type 2 lepra reaction occurrence, observed in lepromatous leprosy and borderline lepromatous cases. It is linked with the involvement of several organs, so if diagnosis and treatment are delayed, it can result in complications and a grim prognosis.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100507"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11728905/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discordance of 3rd and 4th generation QuantiFERON-TB Gold assays by pregnancy stages in India 第三代和第四代QuantiFERON-TB金测定在印度妊娠阶段的不一致。
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2024.100504
Vandana Kulkarni , Mallika Alexander , Ramesh Bhosale , Divyashri Jain , Prasad Deshpande , Emily Shira Gitlin , Arthi Vaidyanathan , Andrea Chalem , Shilpa Naik , Nikhil Gupte , Neelu Nawani , Amita Gupta , Jyoti Mathad

Background

Pregnancy and HIV affect CD4+ T lymphocytes and impact performance of QuantiFERON-TB Gold (QFT). We compared the results of QFT with QuantiFERON-TB Gold Plus (QFT-Plus), which also measures CD8+ responses to TB antigens, during pregnancy and postpartum.

Methods

We screened 516 pregnant women for TB infection (TBI) with IGRA. From 165 IGRA + pregnant women, QFT vs QFT-Plus results were compared at delivery and postpartum. Longitudinal changes in QFT-Plus were assessed in 74 pregnant women who received QFT-Plus testing at pregnancy, delivery, and postpartum.

Results

Through cross-sectional analysis of the IGRA + cohort, QFT-Plus showed higher positivity than QFT (80 % vs 65 %, p = 0.04) at delivery but no difference postpartum. Among 35 women with HIV, QFT-Plus returned more positive results than QFT at delivery and postpartum (76 % vs 47 %, p = 0.08; 90 % vs 80 %, p = 0.54), though not statistically significant. Longitudinally, QFT-Plus positivity by TB1 or TB2 was highest antepartum vs. delivery and postpartum (74 % vs. 58 % vs. 62 %; p = 0.09) and performed better than TB1 alone (100 % vs 90 %, p = 0.04) in women without HIV but not in women with HIV.

Conclusions

Performance of QFT-Plus was consistent across pregnancy, including at delivery when QFT positivity is lower. QFT-Plus may enhance antenatal TBI detection among pregnant women.
背景:妊娠和HIV影响CD4+ T淋巴细胞,影响QuantiFERON-TB Gold (QFT)的性能。我们将QFT的结果与QuantiFERON-TB Gold Plus (QFT-Plus)的结果进行了比较,QFT-Plus也测量了CD8+在怀孕和产后对TB抗原的反应。方法:采用IGRA对516例孕妇进行TB感染筛查。在165名IGRA阳性孕妇中,比较了QFT和QFT- plus在分娩和产后的结果。对74名在怀孕、分娩和产后接受QFT-Plus检测的孕妇进行QFT-Plus的纵向变化评估。结果:通过IGRA +队列的横断面分析,分娩时QFT- plus的阳性率高于QFT (80% vs 65%, p = 0.04),但产后无差异。在35名感染艾滋病毒的妇女中,QFT- plus在分娩和产后的阳性结果比QFT更多(76%比47%,p = 0.08;90% vs 80%, p = 0.54),但没有统计学意义。纵向上,TB1或TB2的QFT-Plus阳性在产前、分娩和产后最高(74%、58%、62%;p = 0.09),并且在未感染艾滋病毒的妇女中优于单独使用TB1 (100% vs 90%, p = 0.04),而在感染艾滋病毒的妇女中则不然。结论:QFT- plus的表现在整个怀孕期间是一致的,包括在分娩时,QFT阳性较低。QFT-Plus可能提高孕妇产前TBI的检测。
{"title":"Discordance of 3rd and 4th generation QuantiFERON-TB Gold assays by pregnancy stages in India","authors":"Vandana Kulkarni ,&nbsp;Mallika Alexander ,&nbsp;Ramesh Bhosale ,&nbsp;Divyashri Jain ,&nbsp;Prasad Deshpande ,&nbsp;Emily Shira Gitlin ,&nbsp;Arthi Vaidyanathan ,&nbsp;Andrea Chalem ,&nbsp;Shilpa Naik ,&nbsp;Nikhil Gupte ,&nbsp;Neelu Nawani ,&nbsp;Amita Gupta ,&nbsp;Jyoti Mathad","doi":"10.1016/j.jctube.2024.100504","DOIUrl":"10.1016/j.jctube.2024.100504","url":null,"abstract":"<div><h3>Background</h3><div>Pregnancy and HIV affect CD4+ T lymphocytes and impact performance of QuantiFERON-TB Gold (QFT). We compared the results of QFT with QuantiFERON-TB Gold Plus (QFT-Plus), which also measures CD8+ responses to TB antigens, during pregnancy and postpartum.</div></div><div><h3>Methods</h3><div>We screened 516 pregnant women for TB infection (TBI) with IGRA. From 165 IGRA + pregnant women, QFT vs QFT-Plus results were compared at delivery and postpartum. Longitudinal changes in QFT-Plus were assessed in 74 pregnant women who received QFT-Plus testing at pregnancy, delivery, and postpartum.</div></div><div><h3>Results</h3><div>Through cross-sectional analysis of the IGRA + cohort, QFT-Plus showed higher positivity than QFT (80 % vs 65 %, p = 0.04) at delivery but no difference postpartum. Among 35 women with HIV, QFT-Plus returned more positive results than QFT at delivery and postpartum (76 % vs 47 %, p = 0.08; 90 % vs 80 %, p = 0.54), though not statistically significant. Longitudinally, QFT-Plus positivity by TB1 or TB2 was highest antepartum vs. delivery and postpartum (74 % vs. 58 % vs. 62 %; p = 0.09) and performed better than TB1 alone (100 % vs 90 %, p = 0.04) in women without HIV but not in women with HIV.</div></div><div><h3>Conclusions</h3><div>Performance of QFT-Plus was consistent across pregnancy, including at delivery when QFT positivity is lower. QFT-Plus may enhance antenatal TBI detection among pregnant women.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100504"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Buruli ulcer: Current landscape, challenges, and future directions
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2024.100490
Rie R. Yotsu , Richard O. Phillips
{"title":"Buruli ulcer: Current landscape, challenges, and future directions","authors":"Rie R. Yotsu ,&nbsp;Richard O. Phillips","doi":"10.1016/j.jctube.2024.100490","DOIUrl":"10.1016/j.jctube.2024.100490","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100490"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143153641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Patient perceptions of video directly observed therapy for tuberculosis: a systematic review” [J. Clin. Tuberc. Other Mycobact. Dis 35 (2024) 100406]
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2024.100484
Angela Mak , Rumia Owaisi , Leah Goldschmidt , Ilo-Katryn Maimets , Amrita Daftary
{"title":"Corrigendum to “Patient perceptions of video directly observed therapy for tuberculosis: a systematic review” [J. Clin. Tuberc. Other Mycobact. Dis 35 (2024) 100406]","authors":"Angela Mak ,&nbsp;Rumia Owaisi ,&nbsp;Leah Goldschmidt ,&nbsp;Ilo-Katryn Maimets ,&nbsp;Amrita Daftary","doi":"10.1016/j.jctube.2024.100484","DOIUrl":"10.1016/j.jctube.2024.100484","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100484"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143153638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary management of multi-drug resistant tuberculosis 耐多药结核病的现代管理方法
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2023.100407
Zelalem Temesgen, James T. Gaensbauer, John W. Wilson
{"title":"Contemporary management of multi-drug resistant tuberculosis","authors":"Zelalem Temesgen,&nbsp;James T. Gaensbauer,&nbsp;John W. Wilson","doi":"10.1016/j.jctube.2023.100407","DOIUrl":"10.1016/j.jctube.2023.100407","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100407"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139014388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculous meningitis-related ischemic stroke: A retrospective study from a tertiary care hospital 结核性脑膜炎相关缺血性脑卒中:来自三级医院的回顾性研究。
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2024.100508
Xuhui Deng , Qiuhui Huang , Hua Huang , Shengri Chen , Xue Wang , Zhijian Liang

Background

Patients with tuberculous meningitis (TBM) are at high risk of ischemic stroke, and stroke is a poor prognosticator of TBM. However, reports regarding the predictors of stroke in TBM patients are scanty. The aim of this study was to investigate the clinical characteristics and predictors of tuberculous meningitis-related ischemic stroke (TBMRIS).

Methods

This retrospective study was conducted among TBM patients without traditional vascular risk factors from a tertiary care hospital between January 2017 and November 2022. Patients were divided into TBMRIS group and TBM-only group according to presence of stroke. Clinical, laboratory and radiological variables were compared between the two groups. Predictors of stroke were identified using binary logistic regression analysis.

Results

A total of 176 TBM patients were included in the study. Forty-nine patients with stroke were classified as TBMRIS group and 127 patients without stroke were classified as TBM-only group. In TBMRIS group, 41 (83.7 %) patients experienced stroke within 3 months after the onset of meningitis symptoms and 10 (20.4 %) patients presented silent stroke. Stroke occurred in basal ganglia in 57.1 % of patients. About 73.5 % of patients showed multiple stroke lesions and 38.8 % of patients had stroke involving multiple vascular territories. There were significant differences in focal neurological deficit, stage of meningitis, short-term outcome, serum sodium, cerebrospinal fluid (CSF) white cell count, CSF adenosine deaminase (ADA), CSF protein, leptomeningeal enhancement, tuberculoma between TBMRIS group and TBM-only group. Binary logistic regression analysis revealed that focal neurological deficit, CSF white cell count and leptomeningeal enhancement were the independent risk factors for stroke, and tuberculoma was negatively correlated with stroke.

Conclusion

Most of TBMRIS develop within 3 months after the onset of meningitis symptoms and basal ganglia is the most frequent site. Multiple stroke lesions and involvement of multiple vascular territories are commonly observed. Focal neurological deficit, CSF white cell count and leptomeningeal enhancement are the predictors of stroke in patients with TBM.
背景:结核性脑膜炎(TBM)患者发生缺血性卒中的风险较高,卒中是TBM的不良预后因素。然而,关于TBM患者中风预测因素的报道很少。本研究的目的是探讨结核性脑膜炎相关缺血性脑卒中(TBMRIS)的临床特征和预测因素。方法:回顾性研究于2017年1月至2022年11月在某三级医院无传统血管危险因素的TBM患者。根据脑卒中情况将患者分为脑mri组和单纯脑mri组。比较两组患者的临床、实验室及影像学指标。采用二元逻辑回归分析确定脑卒中的预测因素。结果:共纳入176例TBM患者。49例脑卒中患者被分为tbmri组,127例非脑卒中患者被分为tbm组。TBMRIS组中,41例(83.7%)患者在出现脑膜炎症状后3个月内发生脑卒中,10例(20.4%)患者出现无症状脑卒中。57.1%的患者发生在基底节区。约73.5%的患者出现多发性脑卒中病变,38.8%的患者卒中累及多血管区域。在局灶性神经功能缺损、脑膜炎分期、短期预后、血清钠、脑脊液白细胞计数、脑脊液腺苷脱氨酶(ADA)、脑脊液蛋白、脑脊液轻脑膜增强、结核瘤等方面,TBMRIS组与单纯tms组差异均有统计学意义。二元logistic回归分析显示局灶性神经功能缺损、脑脊液白细胞计数和脑脊膜轻脑膜增强是脑卒中的独立危险因素,而结核瘤与脑卒中呈负相关。结论:TBMRIS多在出现脑膜炎症状后3个月内发病,基底节区是最常见的发病部位。多发脑卒中病变和多血管区域受累是常见的。局灶性神经功能缺损、脑脊液白细胞计数和脑脊膜轻脑膜增强是TBM患者脑卒中的预测因子。
{"title":"Tuberculous meningitis-related ischemic stroke: A retrospective study from a tertiary care hospital","authors":"Xuhui Deng ,&nbsp;Qiuhui Huang ,&nbsp;Hua Huang ,&nbsp;Shengri Chen ,&nbsp;Xue Wang ,&nbsp;Zhijian Liang","doi":"10.1016/j.jctube.2024.100508","DOIUrl":"10.1016/j.jctube.2024.100508","url":null,"abstract":"<div><h3>Background</h3><div>Patients with tuberculous meningitis (TBM) are at high risk of ischemic stroke, and stroke is a poor prognosticator of TBM. However, reports regarding the predictors of stroke in TBM patients are scanty. The aim of this study was to investigate the clinical characteristics and predictors of tuberculous meningitis-related ischemic stroke (TBMRIS).</div></div><div><h3>Methods</h3><div>This retrospective study was conducted among TBM patients without traditional vascular risk factors from a tertiary care hospital between January 2017 and November 2022. Patients were divided into TBMRIS group and TBM-only group according to presence of stroke. Clinical, laboratory and radiological variables were compared between the two groups. Predictors of stroke were identified using binary logistic regression analysis.</div></div><div><h3>Results</h3><div>A total of 176 TBM patients were included in the study. Forty-nine patients with stroke were classified as TBMRIS group and 127 patients without stroke were classified as TBM-only group. In TBMRIS group, 41 (83.7 %) patients experienced stroke within 3 months after the onset of meningitis symptoms and 10 (20.4 %) patients presented silent stroke. Stroke occurred in basal ganglia in 57.1 % of patients. About 73.5 % of patients showed multiple stroke lesions and 38.8 % of patients had stroke involving multiple vascular territories. There were significant differences in focal neurological deficit, stage of meningitis, short-term outcome, serum sodium, cerebrospinal fluid (CSF) white cell count, CSF adenosine deaminase (ADA), CSF protein, leptomeningeal enhancement, tuberculoma between TBMRIS group and TBM-only group. Binary logistic regression analysis revealed that focal neurological deficit, CSF white cell count and leptomeningeal enhancement were the independent risk factors for stroke, and tuberculoma was negatively correlated with stroke.</div></div><div><h3>Conclusion</h3><div>Most of TBMRIS develop within 3 months after the onset of meningitis symptoms and basal ganglia is the most frequent site. Multiple stroke lesions and involvement of multiple vascular territories are commonly observed. Focal neurological deficit, CSF white cell count and leptomeningeal enhancement are the predictors of stroke in patients with TBM.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100508"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-centers machine learning analysis for predicting acid-fast bacilli results in tuberculosis sputum tests
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2025.100511
Jichong Zhu , Yong Zhao , Chengqian Huang , Chenxing Zhou , Shaofeng Wu , Tianyou Chen , Xinli Zhan

Background

Tuberculosis (TB) is a chronic respiratory infectious disease caused by Mycobacterium tuberculosis, typically diagnosed through sputum smear microscopy for acid-fast bacilli (AFB) to assess the infectivity of TB.

Methods

This study enrolled 769 patients, including 641 patients from the First Affiliated Hospital of Guangxi Medical University as the training group, and 128 patients from Guangxi Hospital of the First Affiliated Hospital of Sun Yat-sen University as the validation group. Among the training cohort, 107 patients were AFB-positive, and 534 were AFB-negative. In the validation cohort, 24 were AFB-positive, and 104 were AFB-negative. Blood samples were collected and analyzed using machine learning (ML) methods to identify key factors for TB diagnosis.

Results

Several ML methods were compared, and support vector machine recursive feature elimination (SVM-RFE) was selected to construct a nomogram diagnostic model. The area under the curve (AUC) of the diagnostic model was 0.721 in the training cohort and 0.758 in the validation cohort. The model demonstrated clinical utility when the threshold was between 38% and 94%, with the NONE line above the ALL line in the decision curve analysis.

Conclusion

We developed a diagnostic model using multiple ML methods to predict AFB results, achieving satisfactory diagnostic performance.
{"title":"Two-centers machine learning analysis for predicting acid-fast bacilli results in tuberculosis sputum tests","authors":"Jichong Zhu ,&nbsp;Yong Zhao ,&nbsp;Chengqian Huang ,&nbsp;Chenxing Zhou ,&nbsp;Shaofeng Wu ,&nbsp;Tianyou Chen ,&nbsp;Xinli Zhan","doi":"10.1016/j.jctube.2025.100511","DOIUrl":"10.1016/j.jctube.2025.100511","url":null,"abstract":"<div><h3>Background</h3><div>Tuberculosis (TB) is a chronic respiratory infectious disease caused by Mycobacterium tuberculosis, typically diagnosed through sputum smear microscopy for acid-fast bacilli (AFB) to assess the infectivity of TB.</div></div><div><h3>Methods</h3><div>This study enrolled 769 patients, including 641 patients from the First Affiliated Hospital of Guangxi Medical University as the training group, and 128 patients from Guangxi Hospital of the First Affiliated Hospital of Sun Yat-sen University as the validation group. Among the training cohort, 107 patients were AFB-positive, and 534 were AFB-negative. In the validation cohort, 24 were AFB-positive, and 104 were AFB-negative. Blood samples were collected and analyzed using machine learning (ML) methods to identify key factors for TB diagnosis.</div></div><div><h3>Results</h3><div>Several ML methods were compared, and support vector machine recursive feature elimination (SVM-RFE) was selected to construct a nomogram diagnostic model. The area under the curve (AUC) of the diagnostic model was 0.721 in the training cohort and 0.758 in the validation cohort. The model demonstrated clinical utility when the threshold was between 38% and 94%, with the NONE line above the ALL line in the decision curve analysis.</div></div><div><h3>Conclusion</h3><div>We developed a diagnostic model using multiple ML methods to predict AFB results, achieving satisfactory diagnostic performance.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100511"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143153639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-tuberculous bronchiectasis in adults: The never-ending story 成人结核后支气管扩张症:永无止境的故事
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2023.100391
Jose Daniel Gómez-Olivas, Grace Oscullo, Miguel Ángel Martínez-García
{"title":"Post-tuberculous bronchiectasis in adults: The never-ending story","authors":"Jose Daniel Gómez-Olivas,&nbsp;Grace Oscullo,&nbsp;Miguel Ángel Martínez-García","doi":"10.1016/j.jctube.2023.100391","DOIUrl":"10.1016/j.jctube.2023.100391","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100391"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44073320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria 印度、印度尼西亚和尼日利亚私营卫生部门的COVID-19政策和结核病服务。
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2025-02-01 DOI: 10.1016/j.jctube.2024.100503
Nathaly Aguilera Vasquez , Charity Oga-Omenka , Vijayashree Yellappa , Bony Wiem Lestari , Angelina Sassi , Surbhi Sheokand , Bolanle Olusola-Faleye , Lavanya Huria , Laura Jane Brubacher , Elaine Baruwa , Bachti Alisjahbana , Madhukar Pai

Introduction

The COVID-19 pandemic created unprecedented challenges in the field of global health. Nigeria, Indonesia and India are three high tuberculosis (TB) burden countries with large private health sectors. Both TB and the private health sector faced challenges in these countries because of COVID-19. This study aimed to compare the COVID-19 control measures and policies in the provision of TB care services and gain insights from policymakers on how the pandemic affected the provision of TB services in the private healthcare sector, how each country adapted, and identify lessons learned for health system preparedness.

Methods

Qualitative, in-depth interviews were conducted among a purposive sample of 11 national and sub-national policymakers in each country. Thematic content analysis was conducted on the data collected using an adapted WHO Health Equity Policy Framework.

Results

Results revealed three policy dimensions under costs, access, and quality. Under healthcare costs, policymakers highlighted resource allocation and diversion of TB resources to COVID response, and increased operational costs for private provider. Under healthcare access, key themes included reduced TB case detection due to fear of COVID-19, disrupted diagnostic services, and adaptations such as extended medicine supplies and tele-consultations. Under healthcare quality, themes included compromised TB diagnostic accuracy due to similar respiratory symptoms with COVID-19, and strain on laboratory infrastructure due to competing demands from both diseases. Policymakers across the three countries pointed to the need for strengthening private–public partnerships (PPP) for healthcare service delivery and continued private sector investment to facilitate the continuity of TB care within a pandemic context.

Conclusion

The results of this study provide an overview of the impact of the pandemic from the perspective of private facilities and policymakers in Nigeria, Indonesia and India, which can inform future policy and ways forward in strengthening PPP for healthcare service delivery in high TB burden countries.
2019冠状病毒病大流行给全球卫生领域带来了前所未有的挑战。尼日利亚、印度尼西亚和印度是结核病高负担国家,拥有庞大的私营卫生部门。由于COVID-19,这些国家的结核病和私营卫生部门都面临挑战。本研究旨在比较在提供结核病治疗服务方面的COVID-19控制措施和政策,并从政策制定者那里了解大流行如何影响私营医疗保健部门提供结核病服务,每个国家如何适应,并确定卫生系统准备工作的经验教训。方法:在每个国家的11个国家级和次国家级政策制定者的有目的样本中进行定性深入访谈。对使用经改编的世卫组织卫生公平政策框架收集的数据进行了专题内容分析。结果:结果揭示了成本、可及性和质量三个政策维度。在医疗成本项下,政策制定者强调了资源分配和结核病资源用于应对COVID的转移,以及私营提供商的运营成本增加。在卫生保健可及性方面,主要主题包括由于对COVID-19的恐惧而减少结核病病例发现、诊断服务中断以及扩大药品供应和远程咨询等适应措施。在卫生保健质量方面,主题包括由于与COVID-19相似的呼吸道症状导致结核病诊断准确性降低,以及由于两种疾病的竞争需求而对实验室基础设施造成压力。三国决策者指出,有必要加强医疗保健服务的公私伙伴关系(PPP),并继续进行私营部门投资,以促进在大流行背景下结核病治疗的连续性。结论:本研究的结果从尼日利亚、印度尼西亚和印度的私营机构和决策者的角度概述了结核病大流行的影响,这可以为未来的政策和在结核病高负担国家加强PPP医疗服务提供的方法提供信息。
{"title":"COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria","authors":"Nathaly Aguilera Vasquez ,&nbsp;Charity Oga-Omenka ,&nbsp;Vijayashree Yellappa ,&nbsp;Bony Wiem Lestari ,&nbsp;Angelina Sassi ,&nbsp;Surbhi Sheokand ,&nbsp;Bolanle Olusola-Faleye ,&nbsp;Lavanya Huria ,&nbsp;Laura Jane Brubacher ,&nbsp;Elaine Baruwa ,&nbsp;Bachti Alisjahbana ,&nbsp;Madhukar Pai","doi":"10.1016/j.jctube.2024.100503","DOIUrl":"10.1016/j.jctube.2024.100503","url":null,"abstract":"<div><h3>Introduction</h3><div>The COVID-19 pandemic created unprecedented challenges in the field of global health. Nigeria, Indonesia and India are three high tuberculosis (TB) burden countries with large private health sectors. Both TB and the private health sector faced challenges in these countries because of COVID-19. This study aimed to compare the COVID-19 control measures and policies in the provision of TB care services and gain insights from policymakers on how the pandemic affected the provision of TB services in the private healthcare sector, how each country adapted, and identify lessons learned for health system preparedness.</div></div><div><h3>Methods</h3><div>Qualitative, in-depth interviews were conducted among a purposive sample of 11 national and sub-national policymakers in each country. Thematic content analysis was conducted on the data collected using an adapted WHO Health Equity Policy Framework.</div></div><div><h3>Results</h3><div>Results revealed three policy dimensions under costs, access, and quality. Under healthcare costs, policymakers highlighted resource allocation and diversion of TB resources to COVID response, and increased operational costs for private provider. Under healthcare access, key themes included reduced TB case detection due to fear of COVID-19, disrupted diagnostic services, and adaptations such as extended medicine supplies and tele-consultations. Under healthcare quality, themes included compromised TB diagnostic accuracy due to similar respiratory symptoms with COVID-19, and strain on laboratory infrastructure due to competing demands from both diseases. Policymakers across the three countries pointed to the need for strengthening private–public partnerships (PPP) for healthcare service delivery and continued private sector investment to facilitate the continuity of TB care within a pandemic context.</div></div><div><h3>Conclusion</h3><div>The results of this study provide an overview of the impact of the pandemic from the perspective of private facilities and policymakers in Nigeria, Indonesia and India, which can inform future policy and ways forward in strengthening PPP for healthcare service delivery in high TB burden countries.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"38 ","pages":"Article 100503"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1